• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Front Immunol . CXCR3 ameliorates neutrophil-dependent disease severity in SARS-CoV-2 infection by regulating CD4+ T cell recruitment

tetano

Editor, Senior Moderator
Front Immunol


. 2026 Jun 11:17:1823264.
doi: 10.3389/fimmu.2026.1823264. eCollection 2026.
CXCR3 ameliorates neutrophil-dependent disease severity in SARS-CoV-2 infection by regulating CD4[SUP]+[/SUP] T cell recruitment

Md Jashim Uddin[SUP] 1 2 [/SUP], Claire Fleming[SUP] 1 3 [/SUP], Nick R Natale[SUP] 1 4 [/SUP], Duncan Hart[SUP] 1 3 [/SUP], Brett Moreau[SUP] 1 [/SUP], Anthony Day[SUP] 5 6 [/SUP], Judith Allen[SUP] 5 6 [/SUP], William A Petri Jr[SUP] 1 3 4 7 [/SUP]


Affiliations
Abstract

Understanding the host immune response to SARS-CoV-2 infection is critical for developing effective immunotherapeutic interventions. Using bulk RNA sequencing of lung tissue from mock-infected and mouse-adapted SARS-CoV-2 strain MA-10-infected mice, we identified CXCL9, CXCL10, and CXCL11 as among the most upregulated transcripts. Notably, their shared receptor, CXCR3, was also upregulated, suggesting activation of the CXCL9/10/11-CXCR3 axis in the lungs. Using spectral flow cytometry, we observed that the increased recruitment of CXCR3[SUP]+[/SUP] immune cells, particularly T cells, innate lymphoid cells (ILCs), and macrophages, correlated with milder disease outcome. Blocking CXCR3 signaling using monoclonal antibodies resulted in worsened disease, which was accompanied by reduced recruitment of T cells, ILCs, and macrophages, and a marked increase in neutrophil infiltration. Depletion of neutrophils using αLy6G antibodies in CXCR3-blocked mice alleviated disease severity, indicating that CXCR3 signaling mitigated neutrophil-driven pathology. CXCR3 blockade failed to exacerbate disease in RAG2[SUP]-/-[/SUP] mice, suggesting that CXCR3-mediated protection requires adaptive immune cells. Adoptive transfer of CD4[SUP]+[/SUP] T cells from wild type (WT), but not CXCR3[SUP]-/-[/SUP], mice conferred protection in RAG2[SUP]-/-[/SUP] mice. Together, our findings establish a protective role for CXCR3-recruited T cells blocking neutrophil infiltration in the lung, highlighting the mechanistic importance of the CXCL9/10/11-CXCR3 axis in protecting the lung from SARS-CoV-2 infection.

Keywords: CD4+T cells; COVID-19; CXCR3; SARS-CoV-2; neutrophils.

 
Back
Top